PEP-010

N/A

Report date: 2025/04/30 11:21:23
NMEFirst In Class

Base Information

Drug NamePEP-010
Drug Alias NamePEP-010DPT C9h
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionCaspase-9 inhibitorsProtein phosphatase 2A inhibitors
TargetsCaspase-9Protein phosphatase 2A
Therapy Area/IndicationsSolid tumoursNeoplasm MetastasisOvarian Neoplasms +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesPEP-Therapy
China Registration ClassN/A

Develop Information

Active CompaniesInstitut CuriePEP-Therapy
Inactive CompaniesN/A
Active IndicationsSolid tumoursNeoplasm MetastasisOvarian Neoplasms +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A